Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer | |
Yuan, Shen-Jun; Xu, Yong-Hong; Wang, Chao; An, Hui-Chao; Xu, Hua-Zhen; Li, Ke; Komatsu, Naoki; Zhao, Li; Chen, Xiao | |
刊名 | JOURNAL OF NANOBIOTECHNOLOGY
![]() |
2019 | |
卷号 | 17期号:1 |
关键词 | Doxorubicin-polyglycerol-nanodiamond conjugate Triple-negative breast cancer Chemoresistance Immunosuppression Immunochemotherapy |
DOI | 10.1186/s12951-019-0541-8 |
URL标识 | 查看原文 |
收录类别 | SCIE |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4233785 |
专题 | 武汉大学 |
推荐引用方式 GB/T 7714 | Yuan, Shen-Jun,Xu, Yong-Hong,Wang, Chao,et al. Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer[J]. JOURNAL OF NANOBIOTECHNOLOGY,2019,17(1). |
APA | Yuan, Shen-Jun.,Xu, Yong-Hong.,Wang, Chao.,An, Hui-Chao.,Xu, Hua-Zhen.,...&Chen, Xiao.(2019).Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer.JOURNAL OF NANOBIOTECHNOLOGY,17(1). |
MLA | Yuan, Shen-Jun,et al."Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer".JOURNAL OF NANOBIOTECHNOLOGY 17.1(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论